Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Total Current Liabilities (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Total Current Liabilities for 2 consecutive years, with $19.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Current Liabilities fell 4.62% to $19.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $19.4 million, a 4.62% decrease, with the full-year FY2024 number at $17.7 million, changed N/A from a year prior.
  • Total Current Liabilities was $19.4 million for Q3 2025 at Pyxis Oncology, up from $17.7 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $20.3 million in Q3 2024 to a low of $14.1 million in Q1 2024.